Regora
Regora is Regorafenib, an oral multi-kinase inhibitor. It is indicated for metastatic colorectal cancer, gastrointestinal stromal tumor, and hepatocellular carcinoma and works by targeting tumor angiogenesis, stromal signaling, and oncogenic kinases.
Features
| Product Name | Regora |
| Generic Name | Regorafenib |
| Formulation | Tablet |
| Available Pack Size | 1X10's |
| Available Strength | 40 mg |